Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
0.492 USD | +3.34% | -0.61% | -43.87% |
Chart calendar Unicycive Therapeutics, Inc.
Upcoming events on Unicycive Therapeutics, Inc.
Past events on Unicycive Therapeutics, Inc.
2024-06-25 08:30 am | UNI-OLC-201 Pivotal Clinical Trial Results Call |
2024-06-20 12:00 pm | Annual General Meeting |
2024-05-30 09:30 am | Lytham Partners Spring Investor Conference |
2024-05-25 06:45 am | European Renal Association Congress |
2024-05-25 06:10 am | European Renal Association Congress |
2024-05-25 06:00 am | European Renal Association Congress |
2024-05-14 06:00 pm | National Kidney Foundation Spring Clinical Meeting - Vandana Mathur, MD |
2024-05-13 04:16 pm | Q1 2024 Earnings Release |
2024-04-18 11:00 am | Noble Capital Markets Emerging Growth Virtual Healthcare Equity Conference |
2024-03-28 04:15 pm | Q4 2023 Earnings Release |
2024-03-12 08:30 pm | International Conference on Advances in Critical Care Nephrology AKI and CRRT - UNI-494 Poster Prese |
2024-03-12 08:30 pm | International Conference on Advances in Critical Care Nephrology AKI and CRRT - UNI-494 Oral Present |
2023-12-06 | Benchmark Company Discovery Conference - One-on-one |
2023-12-04 03:30 pm | Noble Capital Markets Emerging Growth Equity Conference |
2023-11-14 04:15 pm | Q3 2023 Earnings Release |
2023-08-14 05:36 pm | Q2 2023 Earnings Release |
2023-07-25 11:00 am | H.C. Wainwright Kidney Conference |
2023-06-26 12:00 pm | Annual General Meeting |
2023-06-20 09:00 am | Maxim Group Virtual Healthcare Conference |
2023-06-14 | European Renal Association Congress - Shalabh Gupta |
Annual results
Fiscal Period | December | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,95 0,96 -1.02% | 0,68 0,37 83.05% | 0,00 |
EBITDA | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
EBIT Million USD | Released Forecast Spread | 0,00 | -8,98 -8,76 -2.45% | -18,1 -16,6 -8.77% | -20,8 -20,0 -3.7% | -29,3 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 | -10,0 -9,99 -0.32% | -18,1 -16,7 -8.21% | -30,5 -28,7 -6.32% | -40,6 |
Net income Million USD | Released Forecast Spread | -2,26 | -10,0 -9,64 -3.86% | -18,1 -16,6 -8.88% | -31,4 -29,6 -6.08% | -40,8 |
EPS USD | Released Forecast Spread | -0,26 | -0,86 -0,50 -72% | -1,20 -1,09 -10.09% | -1,28 -1,24 -3.5% | -1,08 |
Announcement Date | 18/02/21 | 31/03/22 | 31/03/23 | 28/03/24 | - |
Quarterly results
Fiscal Period | December | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,95 0,00 - | 0,00 0,00 - | 0,68 0,38 80% | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
EBIT Million USD | Released Forecast Spread | -3,54 -2,45 -44.37% | -3,64 -3,41 -6.71% | -5,55 -4,23 -31.45% | -5,33 -3,88 -37.4% | -4,20 -5,70 26.25% | -4,32 -6,33 31.76% | -5,94 -4,60 -29.09% | -6,31 -5,37 -17.63% | -9,20 -6,26 -47.08% | -7,89 | -7,12 | -7,03 | -7,68 | -6,28 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -3,54 -1,90 -86.16% | -3,64 -3,41 -6.63% | -5,56 -4,53 -22.81% | -5,33 -3,97 -34.3% | -14,6 -5,63 -158.79% | -3,84 -6,31 39.13% | -4,33 -4,61 6.01% | -7,80 -6,01 -29.86% | -21,0 -6,28 -233.97% | -7,63 | -7,28 | -7,32 | -7,68 | -6,28 |
Net income Million USD | Released Forecast Spread | -3,54 -2,77 -27.77% | -3,64 -3,45 -5.54% | -5,56 -4,28 -29.98% | -5,33 -3,86 -37.99% | -14,8 -5,72 -157.98% | -4,44 -6,61 32.76% | -4,41 -4,61 4.45% | -8,67 -6,01 -44.3% | -21,2 -6,28 -237.28% | -7,68 | -7,34 | -7,38 | -7,68 | -6,28 |
EPS USD | Released Forecast Spread | -0,24 -0,19 -26.32% | -0,24 -0,23 -5.49% | -0,37 -0,28 -32.14% | -0,35 -0,24 -43.44% | -0,97 -0,37 -160.4% | -0,29 -0,44 33.33% | -0,13 -0,13 0% | -0,16 -0,18 11.11% | -0,61 -0,16 -293.55% | -0,21 | -0,20 | -0,19 | -0,19 | -0,19 |
Announcement Date | 12/05/22 | 15/08/22 | 14/11/22 | 31/03/23 | 16/05/23 | 14/08/23 | 14/11/23 | 28/03/24 | 13/05/24 | - | - | - | - | - |
2024-07-15 01:45 am | ADDLIFE AB: Q2 2024 Earnings Release |
2024-07-21 | MEDPACE HOLDINGS, INC.: Q2 2024 Earnings Release |
2024-07-22 07:00 am | IQVIA HOLDINGS INC.: Q2 2024 Earnings Release |
2024-07-23 | SYNGENE INTERNATIONAL LIMITED: Q1 2025 Earnings Release |
2024-07-23 | ALKERMES PLC: Q2 2024 Earnings Release (Projected) |
2024-07-23 | ICON PUBLIC LIMITED COMPANY: Q2 2024 Earnings Release |
2024-07-24 | LONZA GROUP AG: Q2 2024 Earnings Release |
2024-07-25 01:00 am | BACHEM HOLDING AG: Q2 2024 Earnings Release |
2024-07-25 | PHARVARIS N.V.: Q2 2024 Earnings Release (Projected) |
2024-07-26 01:00 am | BB BIOTECH AG: Q2 2024 Earnings Release |
Past sector events for Unicycive Therapeutics, Inc.
2024-06-07 02:57 am | POLARIS GROUP: May 2024 Sales and Revenue Release |
2024-05-29 04:01 pm | IMMUNOVANT, INC.: Q4 2024 Earnings Release |
2024-05-23 07:00 am | CUREVAC N.V.: Q1 2024 Earnings Release |
2024-05-22 01:00 am | EVOTEC SE: Q1 2024 Earnings Release |
2024-05-21 05:14 pm | ALVOTECH: Q1 2024 Earnings Release |
2024-05-21 07:00 am | EXSCIENTIA PLC: Q1 2024 Earnings Release |
2024-05-17 02:00 am | BIOARCTIC AB: Q1 2024 Earnings Release |
2024-05-15 04:05 pm | CULLINAN THERAPEUTICS, INC.: Q1 2024 Earnings Release |
2024-05-15 07:00 am | PERSPECTIVE THERAPEUTICS, INC.: Q1 2024 Earnings Release |
2024-05-14 | GNI GROUP LTD.: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- UNCY Stock
- Calendar Unicycive Therapeutics, Inc.